ChemoCentryx’s Avacopan Scores European Approval For ANCA
The European Union has approved ChemoCentryx Inc's (NASDAQ: CCXI) Tavneos (avacopan) for…
SpringWorks Therapeutics Announces European Medicines Agency Validation for Marketing Authorization Application of Nirogacestat for the Treatment of Adults with Desmoid Tumors
SpringWorks Therapeutics, Inc.Application based on Phase 3 DeFi trial in which nirogacestat…